Details of the Drug

General Information of Drug (ID: DM9CSWK)

Drug Name

KP-413

Indication

Disease Entry	ICD 11	Status	REF
Atopic dermatitis	EA80	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00932074) A Study to Determine the Safety, Tolerability and Efficacy of KP 13 in Subjects With Atopic Dermatitis(AD). U.S. National Institutes of Health.